Publications by authors named "Laura Testa"

Claim this Profile
R
Reply letter: Pathologic complete response in TNBC: A shield against recurrence, but not the brain?
Gabriel Berlingieri Polho, Yumi Ricucci Shinkado, Leticia Kimie Murazawa, Vinicius Vitor Oliveira, Victor Rocha Pinheiro, Laura Testa

Breast· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune-related adverse events among patients with early-stage triple-negative breast cancer treated with pembrolizumab plus chemotherapy: real-world data from the Neo-Real/GBECAM 0123 study.
Matheus de Oliveira Andrade, Isabella Gonçalves Gutierres, Monique Celeste Tavares, Isadora Martins de Sousa, Flávia Cavalcanti Balint, Laura Testa

Breast· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World 5-Year Outcomes of Patients Treated With the Adjuvant Paclitaxel Trastuzumab (APT) Regimen for Stage I HER2-Positive Early Breast Cancer: A Retrospective International Study.
Soraia Lobo-Martins, Veronique Debien, Elisa Agostinetto, Marianna Sirico, Giselle de Souza Carvalho, Laura Testa

Clin Breast Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Central nervous system relapse in triple-negative breast cancer patients achieving pathological complete response after neoadjuvant chemotherapy: A retrospective cohort analysis.
Gabriel Berlingieri Polho, Yumi Ricucci Shinkado, Leticia Kimie Murazawa, Vinicius Vitor Oliveira, Victor Rocha Pinheiro, Laura Testa

Breast· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer outcomes in patients eligible for adjuvant cyclin-dependent kinase 4 and 6 inhibitors but spared adjuvant chemotherapy by Oncotype Dx: A multicenter retrospective GBECAM 0520 study.
Leandro Jonata de Carvalho Oliveira, Daniela Dornelles Rosa, Artur Katz, Daniele Assad-Suzuki, Daniel Argolo, Laura Testa

Breast· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of potential biomarkers with clinical outcomes in metastatic triple-negative breast cancer treated with pembrolizumab or chemotherapy.
Javier Cortes, Oleg Lipatov, Seock-Ah Im, Anthony Goncalves, Keun Seok Lee, Laura Testa

NPJ Breast Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does Undertreatment With Chemotherapy Impact the Outcomes of Elderly Patients With Early-Stage Breast Cancer? A Real-World Data Analysis.
Jéssica Monteiro Vasconcellos, Renata Colombo Bonadio, Sofia Vidaurre Mendes, Bruna Zanin Orsi, Letícia Vecchi Leis, Laura Testa

Clin Breast Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Subsequent Treatments After Disease Progression on CDK4/6 Inhibitors in Patients With Hormone Receptor-Positive Advanced Breast Cancer.
Lis Victoria Ravani, Pedro Calomeni, Maysa Vilbert, Thiago Madeira, Ming Wang, Laura Testa

JCO Oncol Pract· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathologic complete response rates of patients with ER-low/HER2-negative breast cancer treated with neoadjuvant pembrolizumab plus chemotherapy in the neo-real study.
Renata Colombo Bonadio, Monique Celeste Tavares, Flávia Cavalcanti Balint, Isadora Martins de Sousa, Ana Carolina Marin Comini, Laura Testa

Breast Cancer Res Treat· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world outcomes of women with metastatic breast cancer in visceral crisis treated with chemotherapy: a 15-year cohort from Brazil.
Matheus de Oliveira Andrade, Vitor Hugo Felix, Laura Testa, Renata Colombo Bonadioa

Ecancermedicalscience· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose dense versus 3 weekly AC during neoadjuvant chemoimmunotherapy for triple negative breast cancer.
Renata Colombo Bonadio, Isadora Martins de Sousa, Flávia Cavalcanti Balint, Ana Carolina Marin Comini, Monique Celeste Tavares, Laura Testa

NPJ Breast Cancer· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequency of Radiation Therapy-Induced Malignancies in Patients With Li-Fraumeni Syndrome and Early-Stage Breast Cancer and the Influence of Radiation Therapy Technique.
Vanessa Petry, Renata Colombo Bonadio, Karina Moutinho, Luiz Senna Leite, Laura Testa

Int J Radiat Oncol Biol Phys· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is my patient an appropriate candidate for sentinel node biopsy? Less axillary surgery, for the right patients. Critical review and grades of recommendation.
Jordana de Faria Bessa, Guilherme Garcia Novita, Laura Testa, Ruffo Freitas-Junior, Gustavo Nader Marta

Surg Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global representativeness and impact of funding sources in cost-effectiveness research on systemic therapies for advanced breast cancer: A systematic review.
Felippe Lazar Neto, Marina Acevedo Zarzar de Melo, Cassio Murilo Trovo Hidalgo Filho, Maria Cecília Mathias-Machado, Laura Testa

Breast· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contribution of tumour and immune cells to PD-L1 expression as a predictive biomarker in metastatic triple-negative breast cancer: exploratory analysis from KEYNOTE-119.
Javier Cortes, Eric P Winer, Oleg Lipatov, Seock-Ah Im, Anthony Gonçalves, Laura Testa

J Pathol Clin Res· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Visceral crisis in metastatic breast cancer: an old concept with new perspectives.
Matheus de Oliveira Andrade, Renata Rodrigues da Cunha Colombo Bonadio, Maria Del Pilar Estevez Diz, Laura Testa

Clinics (Sao Paulo)· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of dose reductions on adjuvant abemaciclib efficacy for patients with high-risk early breast cancer: analyses from the monarchE study.
Matthew P Goetz, Irfan Cicin, Laura Testa, Sara M Tolaney, Jens Huober

NPJ Breast Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TROPION-Breast03: a randomized phase III global trial of datopotamab deruxtecan ± durvalumab in patients with triple-negative breast cancer and residual invasive disease at surgical resection after neoadjuvant therapy.
Aditya Bardia, Lajos Pusztai, Kathy Albain, Eva Maria Ciruelos, Seock-Ah Im, Laura Testa

Ther Adv Med Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes.
Priya Rastogi, Joyce O'Shaughnessy, Miguel Martin, Frances Boyle, Javier Cortes, Laura Testa

J Clin Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcomes of neoadjuvant immunotherapy plus chemotherapy in patients with early-stage triple-negative breast cancer: an extracted individual patient data and trial-level meta-analysis.
Mateus Trinconi Cunha, Mariana Carvalho Gouveia, Felippe Lazar Neto, Laura Testa, Paulo Marcelo Hoff

Br J Cancer· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of pembrolizumab versus chemotherapy on health-related quality of life in patients with metastatic triple-negative breast cancer: results from the phase 3 randomised KEYNOTE-119 study.
Peter Schmid, Oleg Lipatov, Seock-Ah Im, Anthony Goncalves, Eva Muñoz-Couselo, Laura Testa

Eur J Cancer· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of capecitabine for central nervous system metastases from breast cancer.
Mariana Carvalho Gouveia, Cassio Murilo Hidalgo Filho, Raquel Andrade Moreno, Heitor Castelo Branco Rodrigues Alves, Aline Sgnolf Ayres, Laura Testa

Ecancermedicalscience· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurovascular and hemodynamic responses to mental stress and exercise in severe COVID-19 survivors.
Diego Faria, Renata Moll-Bernardes, Laura Testa, Camila M V Moniz, Erika C Rodrigues

Am J Physiol Regul Integr Comp Physiol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A matched case-control study of the prognosis of early breast cancer in patients with Li-Fraumeni syndrome (BREAST TP53).
Vanessa Petry, Renata Colombo Bonadio, Laura Testa, Daniela Jbh Cohn, Allyne Cagnacci

Breast· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness analysis of Oncotype DX from a Brazilian private medicine perspective: a GBECAM multicenter retrospective study.
Leandro Jonata Carvalho Oliveira, Thais Baccili Cury Megid, Daniela Dornelles Rosa, Carlos Alberto da Silva Magliano, Daniele Xavier Assad, Laura Testa

Ther Adv Med Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis